Publisher's Synopsis
This work addresses the issues of treating patients with cancer with higher doses of chemotherapy, whether supported by allogeneic bone marrow transplantation, growth factor support, or no extra treatment. Dose intensive therapy is one of the fastest growing and most promising areas of oncology. This text explores this modality for the broad range of malignancies practitioners are likely to encounter in practice.